Erxiekang emplastra as adjunctive therapy for acute gastroenteritis in children: a single-center retrospective cohort study - Scorecard - MDSpire

Erxiekang emplastra as adjunctive therapy for acute gastroenteritis in children: a single-center retrospective cohort study

  • By

  • Cuiyun Fang

  • Yuan Zhou

  • Zhongli Jiang

  • Xiaoxue Su

  • Wei Fan

  • June 11, 2026

  • 0 min

Share

Clinical Scorecard: Evaluation of Erxiekang Emplastra as a Complementary Treatment for Acute Gastroenteritis in Pediatric Patients: A Retrospective Cohort Analysis from a Single Center

At a Glance

CategoryDetail
Condition
Key MechanismsAdjunctive use of Erxiekang Emplastra for symptom control.
Target Population
Care Setting

Key Highlights

    Guideline-Based Recommendations

    Diagnosis

      Management

        Monitoring & Follow-up

          Risks

          • Potential for mild local reactions to Erxiekang Emplastra, as reported in the study.

          Patient & Prescribing Data

          Erxiekang Emplastra serves as a non-oral adjunctive treatment.

          Clinical Best Practices

            Related Resources & Content

            Original Source(s)

            Related Content